DK0403150T3 - Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid - Google Patents

Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid

Info

Publication number
DK0403150T3
DK0403150T3 DK90306143.0T DK90306143T DK0403150T3 DK 0403150 T3 DK0403150 T3 DK 0403150T3 DK 90306143 T DK90306143 T DK 90306143T DK 0403150 T3 DK0403150 T3 DK 0403150T3
Authority
DK
Denmark
Prior art keywords
tigogenin
cellobioside
beta
preparation
synthesis
Prior art date
Application number
DK90306143.0T
Other languages
Danish (da)
English (en)
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0403150T3 publication Critical patent/DK0403150T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Catalysts (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK90306143.0T 1989-06-13 1990-06-06 Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid DK0403150T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/365,588 US5010185A (en) 1989-06-13 1989-06-13 Processes for tigogenin beta-cellobioside

Publications (1)

Publication Number Publication Date
DK0403150T3 true DK0403150T3 (da) 1995-01-16

Family

ID=23439483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90306143.0T DK0403150T3 (da) 1989-06-13 1990-06-06 Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid

Country Status (23)

Country Link
US (1) US5010185A (cs)
EP (1) EP0403150B1 (cs)
JP (1) JPH0637514B2 (cs)
KR (1) KR920002146B1 (cs)
AT (1) ATE114155T1 (cs)
AU (1) AU619986B2 (cs)
CA (1) CA2018722A1 (cs)
CZ (1) CZ279909B6 (cs)
DD (1) DD295164A5 (cs)
DE (1) DE69014152T2 (cs)
DK (1) DK0403150T3 (cs)
ES (1) ES2063269T3 (cs)
FI (1) FI902937A7 (cs)
HU (1) HU210689B (cs)
IE (1) IE64057B1 (cs)
IL (1) IL94650A (cs)
NO (1) NO902600L (cs)
NZ (1) NZ234028A (cs)
PL (3) PL163258B1 (cs)
PT (1) PT94337A (cs)
RU (1) RU2042688C1 (cs)
YU (1) YU47515B (cs)
ZA (1) ZA904527B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
JPH07504921A (ja) * 1992-06-26 1995-06-01 フアイザー・インコーポレイテツド 高コレステロール血症を治療するためのステロイドグリコシド
CA2138016A1 (en) * 1992-06-26 1994-01-06 Kathleen D. Goggin Steroidal beta-o-cellobioside heptaalkanoate process
ATE158299T1 (de) * 1992-06-26 1997-10-15 Pfizer Verfahren zur herstellung von per-acylierten glykosiden
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
PL311278A1 (en) * 1993-04-28 1996-02-05 Pfizer Crystalline glycosidal spirostantil monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
JP4589869B2 (ja) * 2002-07-12 2010-12-01 塩野義製薬株式会社 酸触媒として機能するゼオライト類似体の簡易な製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis

Also Published As

Publication number Publication date
CA2018722A1 (en) 1990-12-13
IL94650A0 (en) 1991-04-15
PL285593A1 (en) 1991-07-01
JPH0637514B2 (ja) 1994-05-18
ZA904527B (en) 1992-01-29
JPH0331297A (ja) 1991-02-12
YU114590A (en) 1991-10-31
FI902937A7 (fi) 1990-12-14
DE69014152D1 (de) 1994-12-22
IL94650A (en) 1994-11-11
YU47515B (sh) 1995-10-03
PL289136A1 (en) 1992-02-24
NO902600L (no) 1990-12-14
AU619986B2 (en) 1992-02-06
ATE114155T1 (de) 1994-12-15
KR920002146B1 (ko) 1992-03-12
EP0403150A2 (en) 1990-12-19
RU2042688C1 (ru) 1995-08-27
PL289135A1 (en) 1992-02-24
PL163219B1 (pl) 1994-02-28
CZ289090A3 (en) 1995-04-12
IE64057B1 (en) 1995-07-12
IE902101L (en) 1990-12-13
CZ279909B6 (cs) 1995-08-16
FI902937A0 (fi) 1990-06-12
KR910000779A (ko) 1991-01-30
EP0403150A3 (en) 1992-06-17
NZ234028A (en) 1991-10-25
PT94337A (pt) 1991-02-08
IE902101A1 (en) 1991-01-02
HU903816D0 (en) 1990-11-28
DD295164A5 (de) 1991-10-24
HUT54708A (en) 1991-03-28
ES2063269T3 (es) 1995-01-01
EP0403150B1 (en) 1994-11-17
PL163258B1 (pl) 1994-02-28
US5010185A (en) 1991-04-23
AU5707990A (en) 1991-08-01
HU210689B (en) 1995-06-28
PL163259B1 (pl) 1994-02-28
DE69014152T2 (de) 1995-03-23
NO902600D0 (no) 1990-06-12

Similar Documents

Publication Publication Date Title
NO901338L (no) Fremgangsmaate til sammenfoeyning av elementer, ved fremstilling av termostrukturelle kompositt materialdeler.
DK0403150T3 (da) Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
DK0417680T3 (da) Fremgangsmåde til fremstilling af 1,1,1,2-tetrafluorethan
DK3095A (da) Fremgangsmåde til fremstilling af 2-aza-4-(alkoxycarbonyl)spiro[4,5]decan-3-oner
DE69013132D1 (de) Verfahren zur Herstellung von Octa-2,7-dien-1-ol.
DE59007794D1 (de) Verfahren zur Herstellung von 2-Chlor-5-chlormethyl-pyridin und neue Zwischenprodukte.
EP0861838A3 (en) Process and intermediates for preparing cryptophycin compounds
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
FI860660A7 (fi) Menetelmä kaasuvirtojen sekoittumisen säätämiseksi.
DK0380288T3 (da) Fremgangsmåde til fremstilling af 1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphtalen
DK0401591T3 (da) Støtteforbindsmaterialer med lav tendens til skumdannelse
DK0441708T3 (da) Fremgangsmåde til fremstilling af terpenketoner
KR970702879A (ko) 신규한 테트라펩티드, 이들의 제조 방법 및 용도(Novel Tetrapeptides, Their Manufacture and Use)
DK1140785T3 (da) Fremgangsmåde til fremstilling af polyhalogenerede paratrifluormethylaniliner
DE69007028D1 (de) Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
ES2016975B3 (es) Compuestos quimicos.
DK0621264T3 (da) Fremgangsmåde til fremstilling af arylbenzylethere
EP0417064A3 (en) Building element, process for its fabrication, mixture as well as cement for the fabrication of this mixture and this element
DK0994849T3 (da) Fremgangsmåde til fremstilling af 2,4,5-triflour-benzonitril
DE69011653D1 (de) Optisch aktive Verbindung, Intermediate hierzu, Verfahren zur Herstellung der Intermediate, und flüssigkristalline Zusammensetzung.
EA200000705A1 (ru) Промежуточные соединения и способ синтеза 17-замещенных 16.бета.-арилокси 4-азастероидов
JPS52122398A (en) Preparation of 02 , 3'-cyclopyrimidinenucleosides